Latest THC Analyst Ratings & Recommendations
Recent analyst recommendations with rating changes and price target updates (last 90 days)
| Date | Analyst | Firm | Action | Rating | Price Target |
|---|---|---|---|---|---|
| Benjamin Rossi | JP Morgan | Maintains | Buy | $280.00 → $260.00 -20.00 (-7.1%) | |
| Zacks Equity Research | Zacks Equity Research | Initiates Coverage | Buy | - | |
| Kevin Fischbeck | BofA Securities | Maintains | Buy | $230.00 | |
| Andrew Mok CFA | Barclays | Maintains | Buy | $257.00 → $238.00 -19.00 (-7.4%) | |
| Michael Ha | Baird | Maintains | Hold | $245.00 → $210.00 -35.00 (-14.3%) | |
| Unknown Analyst | Stephens | Maintains | Buy | $260.00 | |
| David S Macdonald | Truist | Reiterates | Buy | $270.00 | |
| Ryan Langston | TD Cowen | Reiterates | Buy | $242.00 | |
| Scott Fidel | Goldman Sachs | Maintains | Buy | $265.00 → $252.00 -13.00 (-4.9%) | |
| Scott Fidel | Goldman Sachs | Maintains | Buy | $265.00 → $252.00 -13.00 (-4.9%) | |
| Matthew Gillmor CFA | KeyBanc | Maintains | Buy | $250.00 → $225.00 -25.00 (-10.0%) | |
| Jason Cassorla | Guggenheim | Maintains | Buy | $283.00 → $252.00 -31.00 (-10.9%) | |
| Sarah James | Cantor Fitzgerald | Reiterates | Buy | $245.00 | |
| Ben Hendrix | RBC Capital | Reiterates | Buy | $277.00 → $236.00 -41.00 (-14.8%) | |
| Stephen Baxter | Wells Fargo | Initiates Coverage | Buy | $265.00 |
